The possible diffusion of plant-derived vaccine (PDV) biotechnology in developing countries offers an interesting potential substitute to existing more expensive vaccine technology currently available on the market. This paper is concerned with the potential impact that the introduction of such a technology could have on the cost of immunization, and also, more broadly on the incidence of hepatitis B cases on India’s population overtime. The objective of the paper is to look at the hypothetical issues of a PDV diffusion using a system dynamics (SD) model. Some illustrative results are presented to show the interaction between infection rates, mortality rates, and immunization costs. In spite of promising features, such as much lower production costs, institutional hurdles to a widespread diffusion of the technology still need to be overcome.

This is the whole item.

Date created

• 2005 July 17-2005 July 21

Type

• Document

Processing Activity

• Processing documentation available at: https://wiki.albany.edu/display/SCA/Processing+Ingested+Digital+Files

License

• Creative Commons BY-NC-ND Attribution-NonCommercial-NoDerivs 4.0 International

  
  Contact Us for questions or additional rights.

ITEM CONTEXT

Part of

cc5bb0ac12a5b68b26b1583548898dae

Scope and Contents

Part of

3c582e6f5cf305ef0030c7471b499022

Scope and Contents

Part of

23d738ba88f8333bc39725f9cb5bd0b8

Scope and Contents

Collection

System Dynamic Society Records

Scope and Contents

Collecting area

• This collection is part of the University Archives